GLOUCESTER PHARMACEUTICALS INC has a total of 30 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Canada and Mexico. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BOEHRINGER INGELHEIM INT GMBH *, INST OF NUTRACEUTICAL RES PTY and SHANGHAI INST OF CELL BIOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Canada | 7 | |
#3 | Mexico | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | United States | 2 | |
#8 | China | 1 | |
#9 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Fermentation | |
#5 | Implantable devices | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Verdine Gregory L | 15 |
#2 | Keegan Mitchell | 13 |
#3 | Vrolijk Nicholas H | 10 |
#4 | Mcculloch William | 9 |
#5 | Prince Henry Miles | 5 |
#6 | Or Yat Sun | 5 |
#7 | Grant Steven | 4 |
#8 | Bertel Stephan | 3 |
#9 | Stephan Bertel | 1 |
#10 | Vrolijk Nicholas | 1 |
Publication | Filing date | Title |
---|---|---|
CA2732294A1 | Accelerated therapy | |
CA2676387A1 | Combination therapy | |
BRPI0720991A2 | Romidepsin preparation | |
CA2630216A1 | Metabolite derivatives of the hdac inhibitor fk228 |